Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats.
Brakatselos C, Polissidis A, Ntoulas G, Asprogerakas MZ, Tsarna O, Vamvaka-Iakovou A, Nakas G, Delis A, Tzimas P, Skaltsounis L, Silva J, Delis F, Oliveira JF, Sotiropoulos I, Antoniou K.
Brakatselos C, et al. Among authors: oliveira jf.
Neuropsychopharmacology. 2024 Dec;50(2):388-400. doi: 10.1038/s41386-024-01977-1. Epub 2024 Sep 6.
Neuropsychopharmacology. 2024.
PMID: 39242923